Following treatment with MTX or Hyp-PDT, both cancer cell-types exhibited increased release of HMGB1 (Fig. 2B), a DAMP associated to cell's secondary necrosis, following a trend that paralleled the accumulation of secondary necrotic cells in response to these ICD inducers (Suppl. The gene discussed is HMGB1; the disease is cancer.